Wu, Carolyn
Gaier, Eric D.
Nihalani, Bharti R.
Whitecross, Sarah
Hensch, Takao K.
Hunter, David G.
Funding for this research was provided by:
Boston Children's Hospital Translational Research Program Award
Boston Children’s Hospital Ophthalmology Foundation Discovery Award
WPI-IRCN
Article History
Received: 24 May 2022
Accepted: 9 May 2023
First Online: 22 June 2023
Competing interests
: EDG: Luminopia Inc. (scientific advisor, equity, patent). DGH: Rebion, Inc. (founder, equity, patent), Luminopia, Inc. (advisor, equity). CW, BRN, SW, TKH: declare no competing interests.